Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Headline
The study found that collaborative care is clinically effective and cost-effective for older adults with subthreshold depression and reduces the proportion of people who go on to develop case-level depression at 12 months.
Abstract
Background:
Efforts to reduce the burden of illness and personal suffering associated with depression in older adults have focused on those with more severe depressive syndromes. Less attention has been paid to those with mild disorders/subthreshold depression, but these patients also suffer significant impairments in their quality of life and level of functioning. There is currently no clear evidence-based guidance regarding treatment for this patient group.
Objectives:
To establish the clinical effectiveness and cost-effectiveness of a low-intensity intervention of collaborative care for primary care older adults who screened positive for subthreshold depression.
Design:
A pragmatic, multicentred, two-arm, parallel, individually randomised controlled trial with a qualitative study embedded within the pilot. Randomisation occurred after informed consent and baseline measures were collected.
Setting:
Thirty-two general practitioner (GP) practices in the north of England.
Participants:
A total of 705 participants aged ≥ 75 years during the pilot phase and ≥ 65 years during the main trial with subthreshold depression.
Interventions:
Participants in the intervention group received a low-intensity intervention of collaborative care, which included behavioural activation delivered by a case manager for an average of six sessions over 7–8 weeks, alongside usual GP care. Control-arm participants received only usual GP care.
Main outcome measures:
The primary outcome measure was a self-reported measure of depression severity, the Patient Health Questionnaire-9 items PHQ-9 score at 4 months post randomisation. Secondary outcome measures included the European Quality of Life-5 Dimensions, Short Form questionnaire-12 items, Patient Health Questionnaire-15 items, Generalised Anxiety Disorder seven-item scale, Connor–Davidson Resilience Scale two-item version, a medication questionnaire and objective data. Participants were followed up for 12 months.
Results:
In total, 705 participants were randomised (collaborative care n = 344, usual care n = 361), with 586 participants (83%; collaborative care 76%, usual care 90%) followed up at 4 months and 519 participants (74%; collaborative care 68%, usual care 79%) followed up at 12 months. Attrition was markedly greater in the collaborative care arm. Model estimates at the primary end point of 4 months revealed a statistically significant effect in favour of collaborative care compared with usual care [mean difference 1.31 score points, 95% confidence interval (CI) 0.67 to 1.95 score points; p < 0.001]. The difference equates to a standard effect size of 0.30, for which the trial was powered. Treatment differences measured by the PHQ-9 were maintained at 12 months’ follow-up (mean difference 1.33 score points, 95% CI 0.55 to 2.10 score points; p = 0.001). Base-case cost-effectiveness analysis found that the incremental cost-effectiveness ratio was £9633 per quality-adjusted life-year (QALY). On average, participants allocated to collaborative care displayed significantly higher QALYs than those allocated to the control group (annual difference in adjusted QALYs of 0.044, 95% bias-corrected CI 0.015 to 0.072; p = 0.003).
Conclusions:
Collaborative care has been shown to be clinically effective and cost-effective for older adults with subthreshold depression and to reduce the proportion of people who go on to develop case-level depression at 12 months. This intervention could feasibly be delivered in the NHS at an acceptable cost–benefit ratio. Important future work would include investigating the longer-term effect of collaborative care on the CASPER population, which could be conducted by introducing an extension to follow-up, and investigating the impact of collaborative care on managing multimorbidities in people with subthreshold depression.
Trial registration:
Current Controlled Trials ISRCTN02202951.
Funding:
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 8. See the NIHR Journals Library website for further project information.
Contents
- Plain English summary
- Scientific summary
- Chapter 1. Introduction
- Chapter 2. Research objectives
- Chapter 3. Methods
- Chapter 4. Protocol changes
- Chapter 5. Clinical results
- Chapter 6. Economic results
- Chapter 7. Qualitative findings
- Chapter 8. Discussion
- Trial-based estimates of the clinical effectiveness of collaborative care for subthreshold depression
- Summary of trial-based estimates of the cost-effectiveness of collaborative care
- Summary of the main findings from the qualitative examination of acceptability and uptake of collaborative care
- Discussion of the main findings
- Conclusions
- Acknowledgements
- References
- Appendix 1. Regulatory approvals
- Appendix 2. The CASPER trial documents
- Appendix 3. Baseline questionnaire
- Appendix 4. Exploring risk assessment tool
- Appendix 5. The CASPER trial 4-month follow-up questionnaire
- Appendix 6. The CASPER trial 12-month follow-up questionnaire
- Appendix 7. Suicide protocols
- Appendix 8. Zero-inflated negative binomial
- Appendix 9. The CASPER trial participant topic guide
- Appendix 10. The CASPER trial case manager topic guide
- List of abbreviations
About the Series
Article history
The research reported in this issue of the journal was funded by the HTA programme as project number 08/19/04. The contractual start date was in September 2010. The draft report began editorial review in November 2014 and was accepted for publication in September 2015. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.
Declared competing interests of authors
none
Last reviewed: November 2014; Accepted: September 2015.
- NLM CatalogRelated NLM Catalog Entries
- CollAborative care and active surveillance for Screen-Positive EldeRs with subth...CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
- LOC106768580 [Vigna radiata]LOC106768580 [Vigna radiata]Gene ID:106768580Gene
- ATR [Balearica regulorum gibbericeps]ATR [Balearica regulorum gibbericeps]Gene ID:104633663Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...